AMP Comments on Proposed Changes to the Common Rule
Tuesday, October 25, 2011 - 17:00
in Biology & Nature
The Association for Molecular Pathology (AMP) expresses concern that the proposed rule's determination that biospecimens cannot be de-identified will limit validation of clinical tests.